Search results for "Dopamine"

showing 10 items of 660 documents

Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of …

1988

Isolated neurointermediate lobes (NILs) or isolated neural lobes (NLs) of the rat pituitary gland were incubated in Krebs-HEPES solution which contained pargyline and the dopamine uptake inhibitor GBR 12921. The release of endogenous dopamine was determined by HPLC with electrochemical detection. Electrical stimulation of the pituitary stalk induced a frequency-dependent release of dopamine. The release of dopamine from the combined NIL evoked by stimulation at 15 Hz was increased by 130% in the presence of the dopamine D2 receptor antagonist, (-)-sulpiride; the (+)-enantiomer of sulpiride had virtually no effect. When the stimulation frequency was 3 Hz (-)-sulpiride caused an increase in d…

Pituitary glandmedicine.medical_specialtyApomorphineDopamineStimulationIn Vitro Techniques5-Methoxytryptaminechemistry.chemical_compoundDopamineInternal medicinemedicineAnimalsNeurotransmitterPharmacologyPituitary stalkChemistryYohimbineRats Inbred StrainsGeneral MedicineBenzazepinesPargylineElectric StimulationRatsmedicine.anatomical_structureEndocrinologyDopamine receptorPituitary GlandSynapses34-Dihydroxyphenylacetic AcidFemaleSulpirideAntipsychotic Agentsmedicine.drugEndocrine glandNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

The role of cytoplasmic (newly synthesized) dopamine for the spontaneous and electrically evoked release of dopamine and its metabolites from the iso…

1987

Isolated rat NILs were incubated in Krebs-HEPES solution. The release of dopamine and its metabolites (DOPAC, HVA and MOPET) was determined by HPLC with electrochemical detection. The spontaneous release of the sum of metabolites was about 40 times that of dopamine. The spontaneous outflow of dopamine metabolites was unaffected after inhibition of dopamine uptake (by GBR 12921) or after pretreatment with reserpine (5 mg/kg, 12 h before the experiments), but it was reduced by 50% after preincubation with the irreversible DOPA decarboxylase inhibitor, (MFMD, 10 microM, for 10 min). The combination of pretreatment with reserpine and preincubation with MFMD resulted in an 80% inhibition of the …

Pituitary glandmedicine.medical_specialtyCytoplasm3-Methoxy-4-hydroxyphenylethanolReserpineMetaboliteDopamineTetrodotoxinBiologyIn Vitro Techniqueschemistry.chemical_compoundBiosynthesisDopamineInternal medicineparasitic diseasesmedicineAnimalsPharmacologyfungifood and beveragesHomovanillic AcidRats Inbred StrainsGeneral MedicineNeurointermediate lobeReserpineIn vitroElectric StimulationRatsmedicine.anatomical_structureEndocrinologynervous systemchemistryCytoplasmPituitary Gland34-Dihydroxyphenylacetic AcidFemalemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Pituitary Function and the Somatotrophic System in Patients with Idiopathic Parkinson’s Disease Under Chronic Dopaminergic Therapy

2007

Idiopathic Parkinson's disease and dopaminergic medication may influence pituitary hormone secretion. The present study aimed to reveal any abnormalities of the somatotrophic system induced by the disease itself and/or the dopaminergic therapy. Investigations of other pituitary hormones under basal and stimulated conditions, as well as an analysis of body composition, were also performed. This was a controlled diagnostic study in which luteinising hormone-releasing hormone, thyroid-releasing hormone, corticotrophin-releasing hormone and arginine hydrochloride were administered to ten patients with idiopathic Parkinson's disease under dopaminergic medication. Basal and stimulated hormone con…

Pituitary glandmedicine.medical_specialtyEndocrine and Autonomic Systemsbusiness.industryEndocrinology Diabetes and MetabolismDopaminergicProlactinGrowth hormone secretionCellular and Molecular NeuroscienceBasal (phylogenetics)Endocrinologymedicine.anatomical_structureEndocrinologyDopamineInternal medicinemedicinebusinessEndocrine glandHormonemedicine.drugJournal of Neuroendocrinology
researchProduct

Pleasurable music affects reinforcement learning according to the listener.

2013

Mounting evidence links the enjoyment of music to brain areas implicated in emotion and the dopaminergic reward system. In particular, dopamine release in the ventral striatum seems to play a major role in the rewarding aspect of music listening. Striatal dopamine also influences reinforcement learning, such that subjects with greater dopamine efficacy learn better to approach rewards while those with lesser dopamine efficacy learn better to avoid punishments. In this study, we explored the practical implications of musical pleasure through its ability to facilitate reinforcement learning via non-pharmacological dopamine elicitation. Subjects from a wide variety of musical backgrounds chose…

PleasureDopamineAffective neuroscienceEVERYDAY LIFE0302 clinical medicinePARKINSONS-DISEASEReinforcement learningDOPAMINE RELEASEsubjectivityReinforcement learningPsychologyBRAIN-REGIONSOriginal Research ArticleGeneral Psychologyrewardmedia_commonCORRELATEMusic psychology05 social scienceshumanitiesdopaminePsychologypsychological phenomena and processesCognitive psychologyPREDICT INDIVIDUAL-DIFFERENCESreinforcement learningMusic therapymedia_common.quotation_subjectlcsh:BF1-990pleasurebehavioral disciplines and activities050105 experimental psychologyMECHANISMSPleasure03 medical and health sciencesReward systemRewardEMOTION0501 psychology and cognitive sciencesActive listeningmusicmusical experienceListening strategySubjectivitylcsh:PsychologyMusic and emotionhuman activitiesMusic030217 neurology & neurosurgeryRESPONSESMusical experiencelistening strategyFrontiers in psychology
researchProduct

Dopamine interaction with a polyamine cryptand of 1H-pyrazole in the absence and in the presence of Cu(II) ions. Crystal structure of [Cu2(H21L](ClO4…

2000

The crystal structure of the binuclear Cu2+ complex [Cu2(H21L)](ClO4)3·2H2O of the cryptand L = 1,4,7,8,11,14,17,20,21,24,29,32,33,36-tetradecaazapentacyclo[12.12.12.1^(6,9).1^(19,22),1,^31,34]hentetraconta-6,9(41),19(40), 21,31,34(39)-hexaene is presented; evidence for the formation in solution of binary L–dopamine and ternary Cu2+–L– dopamine complexes is presented. Escarti Alemany, Francisco, Francisco.Escarti@uv.es ; Garcia-España Monsonis, Enrique, Enrique.Garcia-Es@uv.es ; Latorre Saborit, Julio, Julio.Latorre@uv.es

PolyamineTernaryUNESCO::QUÍMICA::Química inorgánicaDopamineCrystal structureUNESCO::QUÍMICABinary:QUÍMICA::Química inorgánica [UNESCO]:QUÍMICA [UNESCO]CuDopamine ; Polyamine ; Cu ; Crystal structure ; Binary ; Ternary
researchProduct

Bioinspired catechol-terminated self-assembled monolayers with enhanced adhesion properties

2013

The role of the catechol moiety in the adhesive properties of mussel proteins and related synthetic materials has been extensively studied in the last years but still remains elusive. Here, a simplified model approach is presented based on a self-assembled monolayer (SAM) of upward-facing catechols thiol-bound to epitaxial gold substrates. The orientation of the catechol moieties is confirmed by spectroscopy, which also showed lack of significant amounts of interfering o-quinones. Local force-distance curves on the SAM measured by atomic force microscopy (AFM) shows an average adhesion force of 45 nN, stronger than that of a reference polydopamine coating, along with higher reproducibility …

PolydopamineIndolesPolymersCatecholsBiocompatible MaterialsNanotechnologyMolecular Dynamics Simulationengineering.materialBiomimèticaMicroscopy Atomic ForceBiomaterialsMolecular dynamicschemistry.chemical_compound:Enginyeria química [Àrees temàtiques de la UPC]Coated Materials BiocompatibleCoatingMonolayerMoietyGeneral Materials ScienceMagnetite NanoparticlesAdhesive surfaceCatecholChemistrySAMsAdhesivenessSelf-assembled monolayerGeneral ChemistryAdhesionBiomimetic polymersChemical engineeringCatecholengineeringPrintingMagnetic nanoparticlesBiomimeticGoldBiotechnology
researchProduct

Nitroarene hydrogenation catalysts based on Pd nanoparticles glued with PDA on inorganic supports: Multivariate Curve Resolution as an useful tool to…

2021

[EN] Two green catalysts based on Pd(0) nanoparticles (Pd NPs) anchored through PDA on porous silica and magnetite have been synthesized using a generalized simple and reproducible "two-step" methodology. Both catalysts were tested for a model reaction, the hydrogenation of 4-nitrophenol using NaBH4 as the hydrogenating agent, and especially good activity has been achieved in the case of the catalysts containing magnetite as inorganic core (Pd NPs-PDA@Fe3O4). We analyzed the effect associated with the catalyst separation method (centrifugation or magnetically) that affect to the distribution and aggregation degree of the Pd NPs. In addition, we also correlate the final catalyst morphology w…

PolydopamineNanoparticle010402 general chemistry01 natural sciencesCatalysis4-nitroarenesCatalysisMagnetitechemistry.chemical_compoundPorosityNanoscopic scaleMagnetiteMultivariate curve resolutionMulti-curve resolution factorial analysis010405 organic chemistryProcess Chemistry and TechnologyQUIMICA INORGANICARate-determining stepBimodal porosity0104 chemical scienceschemistryChemical engineeringScientific methodNanoparticlesMesoporous silicaPalladium
researchProduct

Ciprofloxacin releasing gellan gum/polydopamine based hydrogels with near infrared activated photothermal properties.

2021

Abstract In this work, with the aim to obtain a wound dressing hydrogel, an amine derivative of gellan gum was crosslinked in the presence of 4arm-polyethylenglycole-vinylsulfone. Through this easy and reproducible chemical procedure, a hydrogel with advanced elastic properties and hydrolytic resistance under physiological conditions was obtained. The incorporation of different quantities of polydopamine in the gelling solutions allows to obtain different hydrogels with marked photothermal properties when irradiated with a laser in the near infrared at 810 nm. The organic nanoparticles, reacting with the amino groups of the polysaccharide derivative, contribute to increase the storage modul…

PolydopamineStaphylococcus aureusIndolesPolymersPharmaceutical ScienceNanoparticlemacromolecular substancesPolysaccharideHydrolysischemistry.chemical_compoundCiprofloxacinHydrogel antibiotic releasechemistry.chemical_classificationPolysaccharides Bacterialtechnology industry and agricultureHydrogelsPhotothermal therapyAntimicrobialPhotothermal therapyGellan gumchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliverySelf-healing hydrogelsGellag gumNuclear chemistryInternational journal of pharmaceutics
researchProduct

Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other…

2008

Contains fulltext : 69677.pdf (Publisher’s version ) (Closed access) A major goal of genetic studies of attention deficit hyperactivity disorder (ADHD) is to identify individual characteristics that might help segregate the disorder's inherent heterogeneity. [Mill et al. (2006); Arch Ger Psychiatry 63:462-469] recently reported a potentially important association between two dopamine-related risk polymorphisms (DRD4 variable number tandem repeat (VNTR) in exon 3 and DAT1 VNTR in the 3' UTR) and lowered IQ in ADHD. The objective of the current study was to replicate the [Mill et al. (2006); Arch Ger Psychiatry 63:462-469] findings in a clinical sample and to extend the analysis to a large ra…

ProbandMaleGenetics and epigenetic pathways of disease [NCMLS 6]Intelligence2804 Cellular and Molecular NeuroscienceMedizinNeuroinformatics [DCN 3]Receptors DopamineCohort Studies2738 Psychiatry and Mental Health0302 clinical medicineRisk FactorsPerception and Action [DCN 1]MedicineGenetics(clinical)ChildGenetics (clinical)10058 Department of Child and Adolescent Psychiatry3. Good healthVariable number tandem repeatPsychiatry and Mental healthChild PreschoolFemaleFunctional Neurogenomics [DCN 2]Clinical psychology2716 Genetics (clinical)AdolescentGenotypeSingle-nucleotide polymorphism610 Medicine & healthMental health [NCEBP 9]Genomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]mental disordersAttention deficit hyperactivity disorderHumansGenetic Predisposition to Diseaseddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleRisk factorAssociation (psychology)AllelesDopamine Plasma Membrane Transport Proteinsbusiness.industrymedicine.disease030227 psychiatryGenetic defects of metabolism [UMCN 5.1]Genetic markerAttention Deficit Disorder with Hyperactivitybusiness030217 neurology & neurosurgery
researchProduct

Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD

2008

Contains fulltext : 70183.pdf (Publisher’s version ) (Closed access) Previous studies have found heterogeneous association between DAT1-3'-UTR-VNTR and attention deficit hyperactivity disorder (ADHD). Various proportions of conduct disorder (CD) comorbidity in their ADHD samples may partially explain the observational discrepancies. Evidence for this comes from family and twin studies which found ADHD probands with CD (ADHD + CD) are genetically different from those without CD (ADHD - CD). Genotypes of 20 DAT1 markers were analyzed in 576 trios, consisting of 141 ADHD + CD and 435 ADHD - CD. In addition to the classical TDT test, a specific genetic heterogeneity test was performed to identi…

ProbandMaleLinkage disequilibriumGenetics and epigenetic pathways of disease [NCMLS 6]2804 Cellular and Molecular NeuroscienceMedizinComorbidityNeuroinformatics [DCN 3]Linkage Disequilibrium2738 Psychiatry and Mental Health0302 clinical medicineGene FrequencyPerception and Action [DCN 1]Genetics(clinical)ChildGenetics (clinical)GeneticsIncidence10058 Department of Child and Adolescent PsychiatryEuropePsychiatry and Mental healthConduct disorder/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleFunctional Neurogenomics [DCN 2]Conduct DisorderGenetic Markers2716 Genetics (clinical)GenotypeSingle-nucleotide polymorphism610 Medicine & healthBiologyMental health [NCEBP 9]Polymorphism Single Nucleotidebehavioral disciplines and activitiesGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesGenetic HeterogeneityCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]SDG 3 - Good Health and Well-beingmental disordersmedicineAttention deficit hyperactivity disorderHumansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleAllelesDopamine Plasma Membrane Transport ProteinsChi-Square DistributionGenetic heterogeneitymedicine.diseaseTwin study030227 psychiatryGenetic defects of metabolism [UMCN 5.1]HaplotypesAttention Deficit Disorder with Hyperactivity030217 neurology & neurosurgery
researchProduct